Table 2.

Patients per maximum toxicity for treatment-related events (N = 11).

Treatment-Related Adverse Event	Grade 1 n (%)	Grade 2 n (%)	Grade 3 n (%)
Injection site reaction	7 (64%)	0	0
Arthralgia	3 (27%)	1 (9%)	0
Fatigue	3 (27%)	1 (9%)	0
Myositis/myocarditis	0	0	1 (9%)
Rash	1 (9%)	1 (9%)	0
Decreased white blood cell counts	1 (9%)	1 (9%)	0
Decreased platelet counts	0	1 (9%)	0
Hypothyroidism	0	1 (9%)	0
Pneumonitis	1 (9%)	0	0
Alopecia	0	1 (9%)	0
Diarrhea	1 (9%)	0	0
Vision changes (floaters)	1 (9%)	0	0
Pruritis	1 (9%)	0	0
Weight loss	0	1 (9%)	0